KTKristine Rømer Thomsen

Kristine Rømer Thomsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kristine Rømer Thomsen has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Novel police-led intervention for referring people charged with driving under the influence of alcohol or drugs to treatment: a mixed methods feasibility study

    by Lotte Vallentin-Holbech, Bjørn Olsson, Kristine Rømer Thomsen

    Harmful substance use and substance use disorders (SUDs) are major public health issues due to the high prevalence and extensive short-term and long-term consequences on an individual, family, and ...

  • Open Access

    Three-Arm Randomized Controlled Trial of Motivational Interviewing for Adolescent Drinking in Denmark

    by Lotte Vallentin-Holbech, Genevieve F. Dash, Sarah W. Feldstein Ewing, Anette Søgaard Nielsen, Janne S. Tolstrup, Kaare B. Wellnitz, Eva Ørnbøl, Kristine Rømer Thomsen

  • Open Access

    Cannabis use, affect and emotion regulation in daily life: A 3‐week experience sampling method study in people who smoke cannabis almost daily

    by Ana Paula Gonçalves Donate, Janna Cousijn, Emese Kroon, Kristine Rømer Thomsen

    Background and aims: Although many people who use cannabis report mood‐enhancing effects, affective responses are thought to vary within and between individuals. This study examined the bidirectional associations between momentary affect and cannabis use and the potential moderating role of emotion regulation in this. Design: Intensive longitudinal observational study using experience sampling method (ESM). Setting: Denmark. Participants: Adults in Denmark who use cannabis near daily ( n = 113; Age: mean = 31.57 years, median = 29 years, standard deviation = 10.28, inter‐quartile range = 23–36; 60.2% male). Method and measurements: Participants completed a baseline survey (substance use and emotion regulation difficulties) and 21 days of experience sampling (three assessments daily; affect and use). We used multilevel models to assess: (1) the associations between positive affect (PA) and negative affect (NA) and subsequent cannabis use, (2) whether cannabis use predicted changes in affect shortly after use (at the same assessment) and (3) whether cannabis use predicted changes in affect at a later moment (at the next assessment). Next, we assessed whether emotion regulation difficulties moderated associations tested in models 1 and 2. Findings: Higher PA predicted a greater likelihood of cannabis use before the next assessment [odds ratio (OR) = 1.05, 95% confidence interval (CI) = 1.01–1.09], and cannabis use predicted increased PA at the same assessment (b = 0.59, 95% CI = 0.27–0.92), but not at the next assessment. NA was not related to use or vice versa at group level. Emotion regulation difficulties did not statistically significantly moderate the associations between PA or NA and subsequent cannabis use; however, emotion regulation difficulties moderated short‐term effects of cannabis use on NA (b = −0.014, 95% CI = −0.027 to −0.002), with individuals with higher emotion regulation difficulties showing lower NA shortly after use compared with non‐use moments. Conclusions: Within individuals who use cannabis near daily, relatively higher momentary positive affect, but not negative affect, appears to precede and follow cannabis use. Cannabis use appears to be associated with higher positive effect at the time of assessment but does not predict positive affect hours later. Individuals with greater emotion regulation difficulties may experience short‐term reductions in negative effect after cannabis use.

  • Open Access

    Engaging parents in alcohol prevention: evaluation of the parent component in the Our Choice trial

    by Lotte Vallentin-Holbech, Nadine Ezzaaf Fryland, Camilla Krogner Caspersen, Sarah W. Feldstein Ewing, Kristine Rømer Thomsen

  • Open Access

    Beyond cannabis use severity: associations of cannabis product type with sleep quality and mental health

    by Ana Paula Gonçalves Donate, Janna Cousijn, Kristine Rømer Thomsen

    Rationale: People who use cannabis often report using it to improve sleep and/or manage mental health symptoms. Cannabis products differ in their typical cannabinoid composition, particularly in their relative THC and CBD content, which may impact health outcomes differently. Objectives: This naturalistic study investigated associations between cannabis use and related problems, sleep quality, and symptoms of anxiety/depression among people who use cannabis near daily and examined the role of cannabis product types. Methods: Danish adults who reported using cannabis on 26.15 ± 6.23 days/month completed an online survey (197 participants; 64.5% men, M age 30.7 ± 10.63 years) measuring past-month use of cannabis (including product types), severity of cannabis use and related problems (CUDIT-R), sleep quality (B-PSQI), and symptoms of anxiety/depression (PHQ-4). OLS regression models were used to examine associations and interaction terms were used to test moderation. Results: Severity of cannabis use and related problems, as indexed by CUDIT-R, was associated with poorer sleep quality and higher levels of anxiety/depression symptoms, which was not moderated by cannabis product type. Product type explained additional variance in sleep quality, but not in anxiety/depression symptoms. Individuals who reported using hash only and multiple THC-dominant product types exhibited poorer sleep quality compared with those who used flower only, independent of severity of cannabis use and related problems. Conclusions: Severity of cannabis use and related problems was linked with sleep and mental health problems, and product type did not alter the strength of these associations. Use of hash or multiple THC-dominant product was associated with more sleep problems than use of flower, adding to the literature showing that products with greater THC concentration are more harmful. Longitudinal studies are needed to establish causal relationships.

  • Open Access

    Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark

    by Kristine Rømer Thomsen, Birgitte Thylstrup, Morten Hesse, Christian Lindholst, Lotte Ask Reitzel, Tina Stokholm Eriksen, Annette Erlangsen, Amir Englund, Tom P. Freeman, Carsten Hjorthøj

    Background: In recent decades, the potency of cannabis resin increased globally, raising concerns, as higher potency has been associated with increased risk of psychiatric harms at the individual level. The aim here was to examine whether changes over time in the potency of seized cannabis resin samples were associated with psychiatric harms at the population level. Methods: Data on ∆-9-tetrahydrocannabinol (THC) concentration in seized cannabis resin were obtained from forensic departments in Denmark (2000–2022), the country reporting the highest potency in Europe. Data on admissions to cannabis treatment, incidence of cannabis-induced psychosis, and dual diagnosis (schizophrenia and cannabis use disorder) were obtained from national registers. Time-dependent associations between potency and the outcomes were examined with mixed-effects linear regression models and associations across age and sex were explored. Candidate time lags were 0–10 years. Results: THC concentration increased almost fourfold: mean 8.3–31.2% from 2000 to 2022. In fully adjusted models, THC was positively associated with first-time cannabis treatment entry at lags of 0–6, strongest at year 0 ( p < 0.0001); incidence of cannabis-induced psychosis at lags of 0–4, strongest at year 0 ( p < 0.0001); and incidence of dual diagnosis at lags of 0–1, strongest at year 0 ( p < 0.01). No positive associations were found in unadjusted models. Subgroup analyses indicated associations in older patients and women. Conclusions: Potency of seized cannabis resin increased almost fourfold from 2000 to 2022. Changes in cannabis potency were positively associated with psychiatric harms at the population level across all outcomes.


  • Open Access

    The Protocol for: Do peers enhance alcohol use outcomes in group motivational interviewing? A translational clinical trial investigating brain synchrony in underage emerging adults during a fMRI hyperscanning task and its association with 12 month alcohol use reductions

    by Sarah W. Feldstein Ewing, Genevieve F. Dash, Karen A. Hudson, Benedict Hyun, Manshu Yang, Linnea Stahl, Kristine Rømer Thomsen, Ana Paula Gonçalves Donate, Francesca M. Filbey

    Background and Aims: Alcohol is the top substance used by US emerging adults under legal drinking age (underage emerging adults; U-EA; ages 18-19). U-EA are unlikely to seek or receive indicated alcohol interventions. It is imperative to find brief, effective interventions to reduce U-EA drinking. Developmental neuroscience reflects that peers hold higher neural salience during adolescence, as evidenced by differential neural response with real and/or simulated peers, even when those peers were not friends, and particularly in the context of alcohol. Peers also activate positive (prosocial) neural and behavioral responses among adolescents. The role of positive, prosocial peer feedback is consequential given that the most widely-used U-EA platforms for adolescent addiction intervention are group-based interventions. We propose functional magnetic resonance imaging (fMRI) hyperscanning (tandem dyadic scanning) to evaluate U-EA brain response in the underexamined, but widely-utilized, group motivational interviewing (MI). We will examine associations between youth brain synchrony generated in an fMRI hyperscanning task and alcohol use reductions at 12 month follow-up. We hypothesize that greater neural alignment in the social cognition network during positive, prosocial peer interactions (peer-directed change talk) will be associated with greater post-intervention behavior change (lower number of past month drinking days) at 12 months. Design: Within-subjects Setting: UConn Health and UT-Dallas Participants: This study will enroll n=248 U-EA (ages 18-19) with ≥1 past month binge drinking event (4/3 standard drinks per occasion for males/females) via community and campus recruitment Intervention and comparator: Group MI (no comparator; within-subjects) Measurements: This protocol will utilize synchronized fMRI (hyperscanning) to examine positive, prosocial peer-directed health promotive language (peer-directed change talk) directly generated during and extracted from the group MI session. Primary outcomes include fMRI-based hyperscanning metrics (BOLD synchrony in social cognition networks) and behavioral measures (past month alcohol use days measured viaTimeline Followback; TLFB) at 12 months. Secondary outcomes will evaluate the same relationship at 3- and 6-months. Comment: This translational study is crucial for making meaningful gains in adolescent addiction intervention. We could find no peer-reviewed studies examining fMRI hyperscanning in an adolescent addiction intervention context. And, fMRI hyperscanning is at the forefront of interactive, dyadic youth research in socially-relevant and ecologically valid settings. In addition, due to the limited empirical evaluations of group interventions, including group MI, the use of fMRI hyperscanning is timely and offers a unique examination with high clinical impact for young people struggling with addiction.

  • Open Access

    Prevention of alcohol use and promotion of well-being among middle school students: a study protocol for a randomized controlled trial of ADAPT

    by Kristine Rømer Thomsen, Natascha Hareskov, Camilla Krogner Caspersen, Anne Maria Lauenborg, Mette Gammelmark Bergmann, Eva Ørnbøl, Kaare Bro Wellnitz, Sarah W. Feldstein Ewing

    Alcohol use during adolescence has both immediate as well as long-term negative effects; in turn, delaying onset and preventing hazardous use in early adolescence is one essential avenue to protect and bolster adolescents’ socioemotional growth and neurodevelopment. This trial examines the effectiveness, feasibility and acceptability of a novel neurodevelopmentally informed intervention – Adolescent Developmentally-Appropriate health Promotion Therapy (ADAPT) among students in middle school. We hypothesize that, compared to the delayed treatment condition (DT), ADAPT students will show statistically significant behavior change across measures, including: intentions to drink (primary outcome), alcohol use and alcohol-related consequences, well-being and life satisfaction (secondary outcomes) from baseline to 3 months. The study employs a 2-condition cluster randomized controlled trial comparing: (1) ADAPT with a (2) DT condition. Approximately N = 1000 8th grade students (ages 13–15) will be recruited from public middle schools in a global region with elevated rates of adolescent drinking (Denmark; during the school year 2025/2026). Data evaluating primary and secondary outcome measures (e.g., intentions to drink, alcohol use, alcohol-related consequences, well-being, life satisfaction) will be collected via online questionnaires at baseline, and 1- and 3-months post intervention. Feasibility and acceptability will be assessed via attendance in ADAPT group sessions and parent meetings, student surveys, and interviews with middle school staff. This is the first trial to examine effectiveness of the novel neurodevelopmentally informed intervention ADAPT on adolescent drinking and well-being. Novel interventions are needed to address the high prevalence of early drinking and the past decade decline in adolescent well-being, particularly in regions of the globe with elevated adolescent drinking rates. The findings of the study hold substantial significance for the health and well-being of adolescents and can inform evidence-based decisions on alcohol prevention policy, and professional health care practices in Scandinavia and throughout the globe. The trial was registered at ClinicalTrials.gov on August 11th , 2025. ClinicalTrials.gov Identifier: NCT07132866


  • Open Access

    Effect of hypnosis versus mindfulness on self-defined treatment goals and sleep following acquired brain injury: a randomized actively controlled trial

    by Timo L. Kvamme, Jonas Kristoffer Lindeløv, Kristine Rømer Thomsen, Rikke Overgaard, Morten Overgaard

    Introduction: Cognitive rehabilitation for brain injury using hypnosis has received little attention. Methods: Here, we report on self-defined treatment goals and sleep-related outcomes from a randomized actively controlled trial of 49 patients with chronic cognitive sequelae following acquired brain injury. Patients were randomized to two groups, who initially received hypnotic suggestions either from a classical hypnosis tradition (“targeted”) or from a mindfulness tradition (“non-targeted”). Patients set self-defined goals for their everyday lives. Results: After eight sessions, patients reported outcomes (PROs) indicated large improvements with “same” (13%), “better” (44%), “much better” (18%), or “not a problem anymore” (25%). The reported “not a problem anymore” was exclusively reported following hypnosis, not mindfulness. After a 7-week follow-up period both groups experienced a decrease in their need for sleep (~ 55 min/day). Exploratory factor analysis showed that only improvement on objective but not subjective measures (e.g. Working Memory Index, Trail Making Test, and the European Brain Injury Questionnaire scored by a relative) reflected a latent improvement factor. This indicates that subjective reports following hypnotic suggestions should be interpreted cautiously. Conclusion: Based on our findings and converging evidence, we conclude that hypnosis is a promising method in cognitive neurorehabilitation following acquired brain injury, although further high-quality randomized controlled trials are required.